IE
Insider Edges

PARADIGM BIOCAPITAL ADVISORS LP 13F portfolio summary

PARADIGM BIOCAPITAL ADVISORS LP of PARADIGM BIOCAPITAL ADVISORS LP has 35 current stock holdings with a reported portfolio value of $4.89B. The portfolio 1 year return is +84.20%. Top holdings include ACLX (13.55%), RVMD (13.23%), NUVL (11.15%), PCVX (5.69%), EWTX (4.74%).

Back to investors

PARADIGM BIOCAPITAL ADVISORS LP

PARADIGM BIOCAPITAL ADVISORS LP
Latest filing: 2026-03-31

PARADIGM BIOCAPITAL ADVISORS LP runs PARADIGM BIOCAPITAL ADVISORS LP and currently holds 35 stock positions, which is fewer than the average of 229 among the investors we track. The portfolio is valued at approximately $4.89B. Their top 5 holdings are various securities, which collectively represent 0.0% of the portfolio's total weight. PARADIGM BIOCAPITAL ADVISORS LP ranks #156 out of 1000 investors tracked based on their composite Alpha Score. Over the past year, PARADIGM BIOCAPITAL ADVISORS LP's portfolio at PARADIGM BIOCAPITAL ADVISORS LP has delivered returns of +84.21%. Their 3-year annualized return is +112.29%. Looking at the 5-year horizon, PARADIGM BIOCAPITAL ADVISORS LP has achieved +113.66% annualized returns at PARADIGM BIOCAPITAL ADVISORS LP.

Sign in to enable email alerts for this investor.
Top 5 Holdings
No holdings data available
Portfolio Returns
1 Year
+84.21%
#71/1000
3 Year
+112.29%
#180/1000
5 Year
+113.66%
#192/1000

Portfolio Value

$4.89B

Alpha Score

97.4

#156 of 1000

Holdings

35

Showper page

0 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change